First, due to lack of available specimens, the in vitro work was conducted with surrogate HSA tumor vaccines created from patients not included in the clinical case evaluations and utilized a canine monocyte-like cell line rather than monocytes isolated from each specific dog. This evidence concerns the gene ALB and neoplasm.